'Bcg' presentation slideshows

New Drugs and Vaccines in Tuberculosis

748 views • 52 slides

Are galaxies still evolving strongly? Christopher J. Miller

The Effects of Environment. Hubble Heritage Image. On Galaxy Evolution at Low-z. Are galaxies still evolving strongly? Christopher J. Miller. Part I. Defining the questions, methods, and tools of the research topic. Physical Processes of Galaxies. Galaxy Interactions.

475 views • 41 slides

New drugs and vaccines for tuberculosis

587 views • 34 slides

Advances in TB vaccinology

Advances in TB vaccinology. There have been several major changes in the way we look at vaccine in development in the last few years: Advances in bioinformatics/genomics at the bacterial level Identification of targets for vaccines has expanded enormously

834 views • 27 slides

Recognition of BCG Scars

Recognition of BCG Scars. Dr. Earl Hershfield Ms. Barbara Roche Tuberculosis Research Unit University of Manitoba, 2004. BCG Vaccine Usage. International (current): http://www.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragebcg.htm

1.21k views • 24 slides

Sask BCG Discontinuation

Sask BCG Discontinuation. Dr. Ibrahim Khan Saskatchewan TB Education Day 28 th October, 2011. Overview Purpose Background Criteria for use/discontinuation of BCG Discussion. Purpose

372 views • 24 slides

Designing a new prophylactic vaccine as a replacement for BCG

Designing a new prophylactic vaccine as a replacement for BCG. B2 Sultan Gulce Iz Neelam Taneja Murtada Osman. Why do we need a better vaccine?. BCG is the only vaccine currently available Effective against only disseminated and TB meningitis not pulmonary TB in infants and children

365 views • 24 slides

BACILLE CALMETTE-GUERIN DISEASE

453 views • 23 slides

Vaccination and the prospects for TB elimination Christopher Dye World Health Organization

Vaccination and the prospects for TB elimination Christopher Dye World Health Organization. Pulmonary tuberculosis. BCG vaccination trials 1950s. MILLENNIUM DEVELOPMENT GOALS AND BEYOND Halt and begin to reverse incidence by 2015 eliminate TB by 2050.

386 views • 23 slides

Landcare Research, Lincoln Centre for Innovation, Otago University, Dunedin

Towards operational use of BCG vaccine in possums and cattle in New Zealand Graham Nugent 1 , Jackie Whitford 1 , Ivor Yockney 1 , Frank Aldwell 2 , Bryce Buddle 3. Landcare Research, Lincoln Centre for Innovation, Otago University, Dunedin

295 views • 22 slides

BCG Vaccination

BCG Vaccination. Dr Lika Nehaul CCDC / NPHS TB Programme Lead Wales Immunisation Conference 2008. Acknowledgements. Nature (Scientific) Publishing Group Health Protection Agency World Health Organisation. Aspects covered. A brief reminder of some basic facts about TB

1.64k views • 21 slides

John Midturi Kazembe, PN., Schutze, GE., Kline, MW

305 views • 21 slides

BCG Vaccination

BCG Vaccination. Dr Lika Nehaul CCDC / NPHS TB Programme Lead Wales Immunisation Conference 2008. Acknowledgements. Nature (Scientific) Publishing Group Health Protection Agency World Health Organisation. Aspects covered. A brief reminder of some basic facts about TB

361 views • 21 slides

BCG VACCINATION IN THE CONTEXT OF HIV: POLICY AND PRACTICE

BCG VACCINATION IN THE CONTEXT OF HIV: POLICY AND PRACTICE. Anneke C. Hesseling DEWG Child TB Subgroup 13 October 2009. BACKGROUND. BCG: Mycobacterium bovis BCG; live, attenuated vaccine given around birth

327 views • 20 slides

335 views • 18 slides

Changes to the BCG vaccination programme in England

Changes to the BCG vaccination programme in England. Dr Bernadette Purcell CCDC Health Protection Agency. TB: changing epidemiology in UK. 1913: 117,139 new cases E & W 1987: 5086 new cases E & W 2004: 7,000 (London 3,000) Resurgence asstd with changing epidemiology

342 views • 16 slides

Presentation of the CADP toolbox

295 views • 14 slides

Pre - clinical studies

Pre - clinical studies. Out line:. The animal model selected to perform the preclinical studies. The protocol of vaccination Evaluating the safety, immunogenicity and efficacy of the PFP vaccine. The expect results. Guniea pig as Animal model?.

937 views • 12 slides

Opinions about BCG

245 views • 9 slides

Introduction

No. 208. Intravesical BCG for patients with N on M uscle I nvasive Bladder C ancer (NMIBC): Do local results reflect those in the published literature?. Bushra Othman 1 , Daniel Steiner 2 , Sue Wallace 3 , Tania Hossack 4 , Douglas Travis 5 .

74 views • 1 slides